Endothelial dysfunction as a pathogenetic factor in cardiovascular diseases

dc.contributor.advisorSzentmiklósi, József András
dc.contributor.advisordeptDebreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézethu_HU
dc.contributor.authorElhayes, Sarah
dc.contributor.departmentDE--Általános Orvostudományi Karhu_HU
dc.contributor.opponentDrimba, László
dc.contributor.opponentPórszász, Róbert
dc.contributor.opponentdeptKenézy Kórház, Központi Aneszteziológiai és Intezív Terápiás Osztályhu_HU
dc.contributor.opponentdeptDebreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézethu_HU
dc.date.accessioned2022-08-15T11:25:17Z
dc.date.available2022-08-15T11:25:17Z
dc.date.created2022-03-04
dc.description.abstractCardiovascular disease (CVD) is a major cause of morbidity and mortality around the world. The risk factors and treatments have been thoroughly researched and documented, but one crucial element is endothelial dysfunction. Endothelial dysfunction is defined by the reduction of NO-induced vasodilation. The strongest link between endothelial dysfunction and CVD is atherosclerosis. The relationship between endothelial dysfunction and CVD has been solidified by reviewing the mechanisms that cause endothelial dysfunction as well as the major therapies that have shown that reducing or protecting against endothelial dysfunction can lead to better clinical outcomes in relation to CVD.hu_HU
dc.description.correctorhbk
dc.description.courseáltalános orvoshu_HU
dc.description.courselangangolhu_HU
dc.description.degreeegységes, osztatlanhu_HU
dc.format.extent41hu_HU
dc.identifier.urihttp://hdl.handle.net/2437/336479
dc.language.isoenhu_HU
dc.subjectEndothelial dysfunctionhu_HU
dc.subjectCardiovascular diseaseshu_HU
dc.subject.dspaceDEENK Témalista::Orvostudomány::Farmakológiahu_HU
dc.titleEndothelial dysfunction as a pathogenetic factor in cardiovascular diseaseshu_HU
Fájlok